封面
市場調查報告書
商品編碼
1177492

遺傳基因診斷的全球市場:各技術,各類型,各用途,各地區,各國 - 市場規模,考察,競爭,COVID-19影響,預測(2023年~2028年)

Global Genetic Diagnostics Market - Analysis By Technology (Cytogenetic, Biochemical, Molecular), Type, Application, By Region, By Country: Market Size, Insights, Competition, Covid-19 Impact and Forecast (2023-2028)

出版日期: | 出版商: Azoth Analytics | 英文 280 Pages | 訂單完成後即時交付

價格

全球遺傳基因診斷的市場規模,2021年價值106億8,000萬美元,2023年~2028年的預測期間內預計以10.31%的年複合成長率成長。遺傳基因診斷市場,由於遺傳性疾病的病例數增加所牽引。市場地理性的成長,是由於遺傳基因檢驗價值的認識高漲,和由於政府和組織的醫療部門國內投資增加兩者所促進。

本報告提供全球遺傳基因診斷市場相關調查分析,市場動態,COVID-19影響,各市場區隔的市場分析與預測,競爭情形等相關之最新資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 市場動態

  • 促進因素
  • 阻礙因素
  • 機會
  • 趨勢
  • 市場動態的影響評估

第5章 COVID-19影響評估

  • COVID-19對遺傳基因診斷市場的影響度評估
  • 每個地區的COVID-19影響分析(季度)

第6章 波特的五力分析

第7章 宏觀經濟指標預測

  • 國民所得毛額,PPP
  • 全球醫療支出
  • 目前醫療費
  • 全球癌症發生率
  • 製造部門

第8章 競爭定位

  • 企業的產品定位
  • 市場地位矩陣
  • 市場佔有率分析
  • 企業簡介
    • Abbott Laboratories
    • Roche Holding AG
    • Illumina Inc.
    • Thermo Fisher Scientific
    • BioRad Laboratories Inc.
    • Quest Diagnostics Inc.
    • Danaher Corporation
    • Myriad Genetics
    • QIAGEN
    • Baylor Genetics

第9章 全球遺傳基因診斷市場趨勢與預測分析(2018年~2028年)、年複合成長率

  • 宏觀經濟要素的影響指數
  • 全球遺傳基因診斷市場:儀表板
  • 全球遺傳基因診斷的市場規模:各金額(2018年~2028年)
  • 全球遺傳基因診斷市場:概要

第10章 全球遺傳基因診斷市場趨勢與預測分析(2018年~2028年):各類型

  • 全球遺傳基因診斷市場趨勢與預測分析:各類型,概述
  • 預測、發病前檢驗
  • 診斷檢驗
  • 產前檢查、新生兒檢驗
  • 藥物遺傳學檢驗
  • 其他

第11章 全球遺傳基因診斷市場趨勢與預測分析(2018年~2028年):各技術

  • 全球遺傳基因診斷市場趨勢與預測分析:各技術,概述
  • 細胞遺傳學的檢驗
  • 生物化學檢驗
  • 分子檢驗

第12章 全球遺傳基因診斷市場趨勢與預測分析(2018年~2028年):各用途

  • 癌症診斷
  • 遺傳性疾病診斷
  • 心血管疾病診斷
  • 其他

第13章 全球遺傳基因診斷市場趨勢與預測分析(2018年~2028年):各地區

  • 調查對象地區

第14章 南北美洲的遺傳基因診斷市場趨勢與預測分析(2018年~2028年)、年複合成長率

第15章 歐洲的遺傳基因診斷市場趨勢與預測分析(2018年~2028年)、年複合成長率

第16章 亞太地區的遺傳基因診斷市場趨勢與預測分析(2018年~2028年)、年複合成長率

第17章 中東、非洲的遺傳基因診斷市場趨勢與預測分析(2018年~2028年)、年複合成長率

Executive Summary

The Global Genetic Diagnostics market was valued at USD 10.68 billion in 2021 and is expected to grow at a CAGR of 10.31% during the forecast period of 2023-2028. The genetic diagnostics market is driven by a rising number of genetic disorder cases. The growth of the Genetic Diagnostics market geographically is driven both by increasing awareness of the value of genetic testing among the population and increasing national investments in the healthcare sector by the Government and the organizations.

Globally, Cancer accounts for one-sixth of global deaths with up to 10-15% of all cancers caused by inherited genetic changes. Thus, genetic diagnostics play a crucial role in identifying the disease. Cardiovascular diagnostics account for the highest growth in coming years. Moreover, heart-related disorders are mostly inherited from parents to their children. Cardiovascular genomic diagnostics testing, therefore, helps in detecting these inherited diseases such as cardiac channelopathies and congenital heart diseases.

By Type, the Prenatal and newborn genetic diagnostics segment dominates the market due to rising awareness among people about healthcare and increasing mortality rates caused by genetic disorders. Further, the rising geriatric population, technological advancements and increasing demand for genetic testing are factors dominating the share of Molecular Testing.

The increasing pattern of greater awareness among healthcare professionals, doctors and patients towards genetic diagnostics is further expected to strongly boost the global market as well as testing volume across several medical specialities. Further, the adoption of direct-to-consumer genetic testing kits in countries like the United States, China, and Japan is growing rapidly. With increasing technological adoptions, awareness programs, and a decline in costs, the market for DTC-GT kits is likely to witness a significant boost over the forecast period.

Scope of the Report

  • The report presents the analysis of the Genetic Diagnostics market for the historical period of 2018-2021, the estimated year 2022 and the forecast period of 2023-2028.
  • The report analyses the Genetic Diagnostics Market by Value (USD Million).
  • The report analyses the Genetic Diagnostics Market By Type (Predictive and Presymptomatic Testing, Diagnostics Testing, Prenatal and Newborn Testing, Pharmacogenetic Testing, Other Application).
  • The report analyses the Genetic Diagnostics Market By Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing)
  • The report analyses the Genetic Diagnostics Market By Application (Cancer Diagnosis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Other Applications).
  • The Global Genetic Diagnostics Market has been analysed by countries (United States, Canada, Germany, UK, France, Spain, China, Japan, India, Australia).
  • The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by type, by technology, by application.
  • Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Abbott Laboratories, Roche Holding AG, Illumina Inc., Thermo Fisher Scientific, BioRad Laboratories Inc., Quest Diagnostics Inc., Baylor Genetics, Danaher Corporation, Myriad Genetics, QIAGEN.

Key Target Audience

  • Clinics and Hospitals
  • Healthcare Industry
  • Biotechnology Industry
  • Consulting and Advisory Firms
  • Research and Development Organizations

Table of Contents

1. Introduction

  • 1.1 Genetic Diagnostics Overview
  • 1.2 Scope of Research

2. Executive Summary

  • 2.1 Market Dashboard
  • 2.2 Regional Insights
  • 2.3 Market Ecosystem Factors

3. Research Methodology

  • 3.1 Data Collection Process
  • 3.2 Market Trajectory Estimation
  • 3.3 Market Size Calculation

4. Market Dynamics

  • 4.1 Drivers
  • 4.2 Restraints
  • 4.3 Opportunities
  • 4.4 Trends
  • 4.5 Impact assessment of Market Dynamics

5. Covid-19 Impact Assessment

  • 5.1 Assessment of Degree of Impact of Covid-19 on Genetic Diagnostics Market
  • 5.2 Region-Wise Quarterly Covid Impact Analysis

6. Porter's Five Force Analysis

7. Macro Economic Indicator Outlook

  • 7.1 Gross National Income, PPP
  • 7.2 Global Medical Spending
  • 7.3 Current Healthcare Expenditure
  • 7.4 Global Cancer Incidences
  • 7.5 Manufacturing Sector

8. Competitive Positioning

  • 8.1 Companies' Product Positioning
  • 8.2 Market Position Matrix
  • 8.3 Market Share Analysis
  • 8.4 Company Profiling
    • 8.4.1 Abbott Laboratories
    • 8.4.2 Roche Holding AG
    • 8.4.3 Illumina Inc.
    • 8.4.4 Thermo Fisher Scientific
    • 8.4.5 BioRad Laboratories Inc.
    • 8.4.6 Quest Diagnostics Inc.
    • 8.4.7 Danaher Corporation
    • 8.4.8 Myriad Genetics
    • 8.4.9 QIAGEN
    • 8.4.10 Baylor Genetics

9. Global Genetic Diagnostics Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

  • 9.1 Macro Economic Factor Impact Index
  • 9.2 Global Genetic Diagnostics Market: Dashboard
  • 9.3 Global Genetic Diagnostics Market Size, By Value, 2018-2028(USD Million)
  • 9.4 Global Genetic Diagnostics Market: Summary

10. Global Genetic Diagnostics Market Trend And Forecast Analysis, 2018-2028, By Type

  • 10.1 Global Genetic Diagnostics Market Trend And Forecast Analysis, By Type: Snapshot
  • 10.2 Predictive and Presymptomatic Testing
  • 10.3 Diagnostics Testing
  • 10.4 Prenatal and Newborn Testing
  • 10.5 Pharmacogenetic Testing
  • 10.6 Other Application

11. Global Genetic Diagnostics Market Trend And Forecast Analysis, 2018-2028, By Technology

  • 11.1 Global Genetic Diagnostics Market Trend And Forecast Analysis, By Type: Snapshot
  • 11.2 Cytogenetic Testing
  • 11.3 Biochemical Testing
  • 11.4 Molecular Testing

12. Global Genetic Diagnostics Market Trend And Forecast Analysis, 2018-2028, By Application

  • 12.1 Cancer Diagnosis
  • 12.2 Genetic Disease Diagnosis
  • 12.3 Cardiovascular Disease Diagnosis
  • 12.4 Other Application

13. Global Genetic Diagnostics Market Trend And Forecast Analysis, 2018-2028, By Regional Analysis

  • 13.1 Regional Coverage of the Study

14. Americas Genetic Diagnostics Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

  • 14.1 Macro Economic Factor Impact Index
  • 14.2 Impact analysis of market dynamics on the Americas Genetic Diagnostics Market
  • 14.3 Americas Genetic Diagnostics Market: Dashboard
  • 14.4 Americas Genetic Diagnostics Market Size, By Value, 2018-2028(USD Million)
  • 14.5 Americas Genetic Diagnostics Market Trend And Forecast Analysis: Segmentation
    • 14.5.1 By Type
    • 14.5.2 By Technology
    • 14.5.3 By Application
    • 14.5.4 By Country
      • 14.5.4.1 United States
      • 14.5.4.2 Canada
      • 14.5.4.3 Rest of Americas

15. Europe Genetic Diagnostics Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

  • 15.1 Macro Economic Factor Index
  • 15.2 Impact analysis of market dynamics on the Genetic Diagnostics Market
  • 15.3 Europe Genetic Diagnostics Market: Dashboard
  • 15.4 Europe Genetic Diagnostics Market Size, By Value, 2018-2028 (USD Million)
  • 15.5 Europe Genetic Diagnostics Market Trend And Forecast Analysis: Segmentation
    • 15.5.1 By Type
    • 15.5.2 By Technology
    • 15.5.3 By Application
    • 15.5.4 By Country
      • 15.5.4.1 Germany
      • 15.5.4.2 United Kingdom
      • 15.5.4.3 France
      • 15.5.4.4 Spain
      • 15.5.4.5 Rest of Europe

16. Asia Pacific Genetic Diagnostics Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

  • 16.1 Macro Economic Factor Impact Index
  • 16.2 Impact analysis of market dynamics on Asia Pacific Genetic Diagnostics Market
  • 16.3 Asia Pacific Genetic Diagnostics Market: Dashboard
  • 16.4 Asia Pacific Genetic Diagnostics Market Size, By Value, 2018-2028(USD Million)
  • 16.5 Asia Pacific Genetic Diagnostics Market Trend And Forecast Analysis: Segmentation
    • 16.5.1 By Type
    • 16.5.2 By Technology
    • 16.5.3 By Application
    • 16.5.4 By Country
      • 16.5.4.1 China
      • 16.5.4.2 India
      • 16.5.4.3 Japan
      • 16.5.4.4 Australia
      • 16.5.4.5 Rest of APAC

17. Middle East and Africa Genetic Diagnostics Market Trends and Forecast Analysis, 2018-2028, USD Million & CAGR

  • 17.1 Macro Economic Factor Impact Index
  • 17.2 Impact analysis of market dynamics on Genetic Diagnostics Market
  • 17.3 Middle East and Africa Genetic Diagnostics Market: Dashboard
  • 17.4 Middle East and Africa Genetic Diagnostics Market Size, By Value, 2018-2028 (USD Million)
  • 17.5 Middle East and Africa Genetic Diagnostics Market Trend And Forecast Analysis: Segmentation
    • 17.5.1 By Type
    • 17.5.2 By Technology
    • 17.5.3 By Application

List of Figures

List of Figures

  • Figure 1: Genetic Diagnostics Market for next 7 years (in USD Millions)
  • Figure 2: Genetic Diagnostics Market Size, By Type, 2018 & 2028 (USD Million)
  • Figure 3: Genetic Diagnostics Market Size, By Technology, 2021 (%)
  • Figure 4: Market Share of Prominent Companies of Genetic Diagnostics, 2021 (%)
  • Figure 5: Abbott Laboratories Revenues, 2019-2021 (USD Million)
  • Figure 6: Abbott Laboratories Revenues, 2019-2021 (USD Million)
  • Figure 7: Abbott Laboratories Revenue, By Business Segments,2021 (%)
  • Figure 8: Abbott Laboratories Revenue, By Geographic Segments,2021(%)
  • Figure 9: Roche Holding AG Revenues, 2019-2021 (USD Million)
  • Figure 10: Roche Holding AG Revenue, By Business Segments,2021 (%)
  • Figure 11: Roche Holding AG Revenue, By Geographic Segments,2021(%)
  • Figure 12: Illumina Inc. Revenues, 2019-2021 (USD Million)
  • Figure 13: Illumina Inc. Revenue, By Business Segments,2021 (%)
  • Figure 14: Illumina Inc. Revenue, By Geographic Segments,2021(%)
  • Figure 15: Thermo Fisher Scientific Revenues, 2019-2021 (USD Million)
  • Figure 16: Thermo Fisher Scientific Revenue, By Business Segments,2021 (%)
  • Figure 17: Thermo Fisher Scientific Revenue, By Geographic Segments,2021(%)
  • Figure 18: Bio-Rad Laboratories Revenues, 2019-2021 (USD Million)
  • Figure 19: Bio-Rad Laboratories Revenue, By Business Segments,2021 (%)
  • Figure 20: Bio-Rad Laboratories Revenue, By Geographic Segments,2021(%)
  • Figure 21: Quest Diagnostics Revenues, 2019-2021 (USD Million)
  • Figure 22: Quest Diagnostics Revenue, By Business Segments,2021 (%)
  • Figure 23: Quest Diagnostics Revenue, By Business Segments,2020 (%)
  • Figure 24: Danaher Corporation Revenues, 2019-2021 (USD Million)
  • Figure 25: Danaher Corporation Revenue, By Business Segments,2021 (%)
  • Figure 26: Danaher Corporation Revenue, By Geographical Segments,2021 (%)
  • Figure 27: Myriad Genetics Revenues, 2019-2021 (USD Million)
  • Figure 28: Myriad Genetics Revenue, By Business Segments,2021 (%)
  • Figure 29: Myriad Genetics Revenue, By Geographical Segments,2021 (%)
  • Figure 30: QIAGEN Revenues, 2019-2021 (USD Million)
  • Figure 31: QIAGEN Revenue, By Business Segments,2021 (%)
  • Figure 32: QIAGEN Revenue, By Geographical Segments,2021 (%)
  • Figure 33: At a CAGR of 10.31% during 2023-2028, the global market value is expected to reach USD 19148.50 MILLION in 2028
  • Figure 34: Global market value of Genetic Diagnostics is expected to sustain a staggering growth of USD 7425.35 Million from 2023-2028
  • Figure 35: Basis Point Analysis of Global Genetic Diagnostics Market, By Region (2022,2028)
  • Figure 36: Market Opportunity Analysis of Global Genetic Diagnostics Market, By Region (2023-2028)
  • Figure 37: Global Genetic Diagnostics Market Size, By Value, 2018-2021(USD MILLION)
  • Figure 38: Global Genetic Diagnostics Market Size, By Value, 2022-2028 (USD MILLION)
  • Figure 39: Global Genetic Diagnostics Market Share, By Application, 2021 (%)
  • Figure 40: Global Genetic Diagnostics Market CAGR, By Type, By Value, 2018-2021, 2023-2028(%)
  • Figure 41: Basis Point Analysis of Global Genetic Diagnostics Market, By Type (2022,2028)
  • Figure 42: Market Opportunity Analysis of Global Genetic Diagnostics Market, By Type (2023-2028)
  • Figure 43: Global Genetic Diagnostics Market Size, Predictive and Presymptomatic Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 44: Global Genetic Diagnostics Market Size, Predictive and Presymptomatic Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 45: Global Predictive and Presymptomatic Testing Market Absolute Opportunity, 2018-2028 (USD MILLION)
  • Figure 46: Global Genetic Diagnostics Market Size, Diagnostics Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 47: Global Genetic Diagnostics Market Size, Diagnostics Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 48: Global Diagnostics Testing Market Absolute Opportunity, 2018-2028 (USD MILLION)
  • Figure 49: Global Genetic Diagnostics Market Size, Prenatal and Newborn Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 50: Global Genetic Diagnostics Market Size, Prenatal and Newborn Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 51: Global Prenatal and Newborn Testing Market Absolute Opportunity, 2018-2028 (USD MILLION)
  • Figure 52: Global Genetic Diagnostics Market Size, Pharmacogenetic Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 53: Global Genetic Diagnostics Market Size, Pharmacogenetic Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 54: Global Pharmacogenetic Testing Market Absolute Opportunity, 2018-2028 (USD MILLION)
  • Figure 55: Global Genetic Diagnostics Market Size, Others, By Value, 2018-2021 (USD MILLION)
  • Figure 56: Global Genetic Diagnostics Market Size, Others, By Value, 2022-2028 (USD MILLION)
  • Figure 57: Global Others Market Absolute Opportunity, 2018-2028 (USD MILLION)
  • Figure 58: Global Genetic Diagnostics Market CAGR, By Technology, By Value, 2018-2021, 2023-2028 (%)
  • Figure 59: Basis Point Analysis of Global Genetic Diagnostics Market, By Technology (2022,2028)
  • Figure 60: Market Opportunity Analysis of Global Genetic Diagnostics Market, By Technology (2023-2028)
  • Figure 61: Global Genetic Diagnostics Market Size, By Cytogenetic Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 62: Global Genetic Diagnostics Market Size, By Cytogenetic Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 63: Global Cytogenetic Testing Market Absolute Opportunity, By Value, 2018-2028 (USD MILLION)
  • Figure 64: Global Genetic Diagnostics Market Size, By Biochemical Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 65: Global Genetic Diagnostics Market Size, By Biochemical Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 66: Global Biochemical Testing Market Absolute Opportunity, By Value, 2018-2028 (USD MILLION)
  • Figure 67: Global Genetic Diagnostics Market Size, By Molecular Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 68: Global Genetic Diagnostics Market Size, By Molecular Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 69: Global Molecular Testing Market Absolute Opportunity, By Value, 2018-2028 (USD MILLION)
  • Figure 70: Global Genetic Diagnostics Market CAGR, By Application, By Value, 2018-2021, 2023-2028 (%)
  • Figure 71: Basis Point Analysis of Global Genetic Diagnostics Market, By Application (2022,2028)
  • Figure 72: Market Opportunity Analysis of Global Genetic Diagnostics Market, By Application (2023-2028)
  • Figure 73: Global Genetic Diagnostics Market Size, By Cancer Diagnosis, By Value, 2018-2021 (USD MILLION)
  • Figure 74: Global Genetic Diagnostics Market Size, By Cancer Diagnosis, By Value, 2022-2028 (USD MILLION)
  • Figure 75: Global Cancer Diagnosis Market Absolute Opportunity, By Value, 2018-2028 (USD MILLION)
  • Figure 76: Global Genetic Diagnostics Market Size, By Genetic Disease Diagnosis, By Value, 2018-2021 (USD MILLION)
  • Figure 77: Global Genetic Diagnostics Market Size, By Genetic Disease Diagnosis, By Value, 2022-2028 (USD MILLION)
  • Figure 78: Global Genetic Disease Diagnosis Market Absolute Opportunity, By Value, 2018-2028 (USD MILLION)
  • Figure 79: Global Genetic Diagnostics Market Size, By Cardiovascular Disease Diagnosis, By Value, 2018-2021 (USD MILLION)
  • Figure 80: Global Genetic Diagnostics Market Size, By Cardiovascular Disease Diagnosis, By Value, 2022-2028 (USD MILLION)
  • Figure 81: Global Cardiovascular Disease Diagnosis Market Absolute Opportunity, By Value, 2018-2028 (USD MILLION)
  • Figure 82: Global Genetic Diagnostics Market Size, By Others, By Value, 2018-2021 (USD MILLION)
  • Figure 83: Global Genetic Diagnostics Market Size, By Others, By Value, 2022-2028 (USD MILLION)
  • Figure 84: Global Others Market Absolute Opportunity, By Value, 2018-2028 (USD MILLION)
  • Figure 85: Market Value of the Americas is expected to grow from USD 4167.98 Mn to USD 7965.78 Mn in 2028
  • Figure 86: Americas Genetic Diagnostics Market is expected to foresee an absolute opportunity USD 3797.79 Mn during 2018-2028
  • Figure 87: Market Value, by Type
  • Figure 88: Market Value, by Technology
  • Figure 89: Top 3 Countries of Genetic Diagnostics Market in Americas
  • Figure 90: Basis Point Analysis of Americas Genetic Diagnostics Market, By Country (2022,2028)
  • Figure 91: Market Opportunity Analysis of Americas Genetic Diagnostics Market, By Country (2023-2028)
  • Figure 92: Americas Genetic Diagnostics Market Size, By Value, 2018-2021(USD MILLION)
  • Figure 93: Americas Genetic Diagnostics Market Size, By Value, 2022-2028 (USD MILLION)
  • Figure 94: Americas Genetic Diagnostics Market Share, By Application, 2021 (%)
  • Figure 95: Americas Genetic Diagnostics Market CAGR, By Type, By Value, 2018-2021, 2023-2028(%)
  • Figure 96: Basis Point Analysis of Americas Genetic Diagnostics Market, By Type (2022,2028)
  • Figure 97: Market Opportunity Analysis of Americas Genetic Diagnostics Market, By Type (2023-2028)
  • Figure 98: Americas Genetic Diagnostics Market Size, Predictive and Presymptomatic Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 99: Americas Genetic Diagnostics Market Size, Predictive and Presymptomatic Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 100: Americas Predictive and Presymptomatic Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 101: Americas Genetic Diagnostics Market Size, Diagnostics Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 102: Americas Genetic Diagnostics Market Size, Diagnostics Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 103: Americas Diagnostics Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 104: Americas Genetic Diagnostics Market Size, Prenatal and Newborn Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 105: Americas Genetic Diagnostics Market Size, Prenatal and Newborn Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 106: Americas Prenatal and Newborn Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 107: Americas Genetic Diagnostics Market Size, Pharmacogenetic Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 108: Americas Genetic Diagnostics Market Size, Pharmacogenetic Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 109: Americas Pharmacogenetic Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 110: Americas Genetic Diagnostics Market Size, Others, By Value, 2018-2021 (USD MILLION)
  • Figure 111: Americas Genetic Diagnostics Market Size, Others, By Value, 2022-2028 (USD MILLION)
  • Figure 112: Americas Others Footprint in Global Market, 2021 (% of Global Market)
  • Figure 113: Americas Genetic Diagnostics Market CAGR, By Technology, By Value, 2018-2021, 2023-2028 (%)
  • Figure 114: Basis Point Analysis of Americas Genetic Diagnostics Market, By Technology(2022,2028)
  • Figure 115: Market Opportunity Analysis of Americas Genetic Diagnostics Market, By Technology(2023-2028)
  • Figure 116: Americas Genetic Diagnostics Market Size, By Cytogenetic Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 117: Americas Genetic Diagnostics Market Size, By Cytogenetic Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 118: Americas Cytogenetic Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 119: Americas Genetic Diagnostics Market Size, By Biochemical Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 120: Americas Genetic Diagnostics Market Size, By Biochemical Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 121: Americas Biochemical Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 122: Americas Genetic Diagnostics Market Size, By Molecular Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 123: Americas Genetic Diagnostics Market Size, By Molecular Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 124: Americas Molecular Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 125: Americas Genetic Diagnostics Market CAGR, By Application, By Value, 2018-2021, 2023-2028 (%)
  • Figure 126: Basis Point Analysis of Americas Genetic Diagnostics Market, By Application (2022,2028)
  • Figure 127: Market Opportunity Analysis of Americas Genetic Diagnostics Market, By Application (2023-2028)
  • Figure 128: Americas Genetic Diagnostics Market Size, By Cancer Diagnosis, By Value, 2018-2021 (USD MILLION)
  • Figure 129: Americas Genetic Diagnostics Market Size, By Cancer Diagnosis, By Value, 2022-2028 (USD MILLION)
  • Figure 130: Americas Cancer Diagnosis Footprint in Global Market, 2021 (% of Global Market)
  • Figure 131: Americas Genetic Diagnostics Market Size, By Genetic Disease Diagnosis, By Value, 2018-2021 (USD MILLION)
  • Figure 132: Americas Genetic Diagnostics Market Size, By Genetic Disease Diagnosis, By Value, 2022-2028 (USD MILLION)
  • Figure 133: Americas Genetic Disease Diagnosis Footprint in Global Market, 2021 (% of Global Market)
  • Figure 134: Americas Genetic Diagnostics Market Size, By Cardiovascular Disease Diagnosis, By Value, 2018-2021 (USD MILLION)
  • Figure 135: Americas Genetic Diagnostics Market Size, By Cardiovascular Disease Diagnosis, By Value, 2022-2028 (USD MILLION)
  • Figure 136: Americas Cardiovascular Disease Diagnosis Footprint in Global Market, 2021 (% of Global Market)
  • Figure 137: Americas Genetic Diagnostics Market Size, By Others, By Value, 2018-2021 (USD MILLION)
  • Figure 138: Americas Genetic Diagnostics Market Size, By Others, By Value, 2022-2028 (USD MILLION)
  • Figure 139: Americas Others Footprint in Global Market, 2021 (% of Global Market)
  • Figure 140: United States Genetic Diagnostics Market, By Value, 2018-2028 (USD Million)
  • Figure 141: United States Genetic Diagnostics Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 142: United States Genetic Diagnostics Market Value, By Type, 2021 (USD Million)
  • Figure 143: United States Genetic Diagnostics Market Share, By Type, By Value, 2021 (%)
  • Figure 144: United States Genetic Diagnostics Market Share, By Technology, By Value, 2021 (%)
  • Figure 145: United States Genetic Diagnostics Market Share, By Application, By Value, 2021 (%)
  • Figure 146: Canada Genetic Diagnostics Market, By Value, 2018-2028 (USD Million)
  • Figure 147: Canada Genetic Diagnostics Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 148: Canada Genetic Diagnostics Market Value, By Type, 2021 (USD Million)
  • Figure 149: Canada Genetic Diagnostics Market Share, By Type, By Value, 2021 (%)
  • Figure 150: Canada Genetic Diagnostics Market Share, By Technology, By Value, 2021 (%)
  • Figure 151: Canada Genetic Diagnostics Market Share, By Application, By Value, 2021 (%)
  • Figure 152: Rest of Americas Genetic Diagnostics Market, By Value, 2018-2028 (USD Million)
  • Figure 153: Rest of Americas Genetic Diagnostics Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 154: Rest of Americas Genetic Diagnostics Market Value, By Type, 2021 (USD Million)
  • Figure 155: Rest of Americas Genetic Diagnostics Market Share, By Type, By Value, 2021 (%)
  • Figure 156: Rest of Americas Genetic Diagnostics Market Share, By Technology, By Value, 2021 (%)
  • Figure 157: Rest of Americas Genetic Diagnostics Market Share, By Application, By Value, 2021 (%)
  • Figure 158: Market Value of the Europe is expected to grow from USD 2597.68 Mn to USD 5401.79 Mn in 2028
  • Figure 159: Europe Genetic Diagnostics Market is expected to foresee an absolute opportunity of USD 2804.11 Mn during 2018-2028
  • Figure 160: Market Value, by Type
  • Figure 161: Market Value, by Technology
  • Figure 162: Top 3 Countries of Genetic Diagnostics Market in Europe
  • Figure 163: Basis Point Analysis of Europe LEO Satellite Market, By Country (2022,2028)
  • Figure 164: Market Opportunity Analysis of Europe Genetic Diagnostics Market, By Country (2023-2028)
  • Figure 165: Europe Genetic Diagnostics Market Size, By Value, 2018-2021(USD MILLION)
  • Figure 166: Europe Genetic Diagnostics Market Size, By Value, 2022-2028 (USD MILLION)
  • Figure 167: Europe Genetic Diagnostics Market Share, By Application, 2021 (%)
  • Figure 168: Europe Genetic Diagnostics Market CAGR, By Type, By Value, 2018-2021, 2023-2028(%)
  • Figure 169: Basis Point Analysis of Europe Genetic Diagnostics Market, By Type (2022,2028)
  • Figure 170: Market Opportunity Analysis of Europe Genetic Diagnostics Market, By Type (2023-2028)
  • Figure 171: Europe Genetic Diagnostics Market Size, Predictive and Presymptomatic Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 172: Europe Genetic Diagnostics Market Size, Predictive and Presymptomatic Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 173: Europe Predictive and Presymptomatic Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 174: Europe Genetic Diagnostics Market Size, Diagnostics Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 175: Europe Genetic Diagnostics Market Size, Diagnostics Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 176: Europe Diagnostics Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 177: Europe Genetic Diagnostics Market Size, Prenatal and Newborn Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 178: Europe Genetic Diagnostics Market Size, Prenatal and Newborn Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 179: Europe Prenatal and Newborn Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 180: Europe Genetic Diagnostics Market Size, Pharmacogenetic Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 181: Europe Genetic Diagnostics Market Size, Pharmacogenetic Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 182: Europe Pharmacogenetic Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 183: Europe Genetic Diagnostics Market Size, Others, By Value, 2018-2021 (USD MILLION)
  • Figure 184: Europe Genetic Diagnostics Market Size, Others, By Value, 2022-2028 (USD MILLION)
  • Figure 185: Europe Others Footprint in Global Market, 2021 (% of Global Market)
  • Figure 186: Europe Genetic Diagnostics Market CAGR, By Technology, By Value, 2018-2021, 2023-2028 (%)
  • Figure 187: Basis Point Analysis of Europe Genetic Diagnostics Market, By Technology(2022,2028)
  • Figure 188: Market Opportunity Analysis of Europe Genetic Diagnostics Market, By Technology(2023-2028)
  • Figure 189: Europe Genetic Diagnostics Market Size, By Cytogenetic Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 190: Europe Genetic Diagnostics Market Size, By Cytogenetic Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 191: Europe Cytogenetic Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 192: Europe Genetic Diagnostics Market Size, By Biochemical Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 193: Europe Genetic Diagnostics Market Size, By Biochemical Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 194: Europe Biochemical Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 195: Europe Genetic Diagnostics Market Size, By Molecular Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 196: Europe Genetic Diagnostics Market Size, By Molecular Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 197: Europe Molecular Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 198: Europe Genetic Diagnostics Market CAGR, By Application, By Value, 2018-2021, 2023-2028 (%)
  • Figure 199: Basis Point Analysis of Europe Genetic Diagnostics Market, By Application (2022,2028)
  • Figure 200: Market Opportunity Analysis of Europe Genetic Diagnostics Market, By Application (2023-2028)
  • Figure 201: Europe Genetic Diagnostics Market Size, By Cancer Diagnosis, By Value, 2018-2021 (USD MILLION)
  • Figure 202: Europe Genetic Diagnostics Market Size, By Cancer Diagnosis, By Value, 2022-2028 (USD MILLION)
  • Figure 203: Europe Cancer Diagnosis Footprint in Global Market, 2021 (% of Global Market)
  • Figure 204: Europe Genetic Diagnostics Market Size, By Genetic Disease Diagnosis, By Value, 2018-2021 (USD MILLION)
  • Figure 205: Europe Genetic Diagnostics Market Size, By Genetic Disease Diagnosis, By Value, 2022-2028 (USD MILLION)
  • Figure 206: Europe Genetic Disease Diagnosis Footprint in Global Market, 2021 (% of Global Market)
  • Figure 207: Europe Genetic Diagnostics Market Size, By Cardiovascular Disease Diagnosis, By Value, 2018-2021 (USD MILLION)
  • Figure 208: Europe Genetic Diagnostics Market Size, By Cardiovascular Disease Diagnosis, By Value, 2022-2028 (USD MILLION)
  • Figure 209: Europe Cardiovascular Disease Diagnosis Footprint in Global Market, 2021 (% of Global Market)
  • Figure 210: Europe Genetic Diagnostics Market Size, By Others, By Value, 2018-2021 (USD MILLION)
  • Figure 211: Europe Genetic Diagnostics Market Size, By Others, By Value, 2022-2028 (USD MILLION)
  • Figure 212: Europe Others Footprint in Global Market, 2021 (% of Global Market)
  • Figure 213: Germany Genetic Diagnostics Market, By Value, 2018-2028 (USD Million)
  • Figure 214: Germany Genetic Diagnostics Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 215: Germany Genetic Diagnostics Market Value, By Type, 2021 (USD Million)
  • Figure 216: Germany Genetic Diagnostics Market Share, By Type, By Value, 2021 (%)
  • Figure 217: Germany Genetic Diagnostics Market Share, By Technology, By Value, 2021 (%)
  • Figure 218: Germany Genetic Diagnostics Market Share, By Application, By Value, 2021 (%)
  • Figure 219: United Kingdom Genetic Diagnostics Market, By Value, 2018-2028 (USD Million)
  • Figure 220: United Kingdom Genetic Diagnostics Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 221: United Kingdom Genetic Diagnostics Market Value, By Type, 2021 (USD Million)
  • Figure 222: United Kingdom Genetic Diagnostics Market Share, By Type, By Value, 2021 (%)
  • Figure 223: United Kingdom Genetic Diagnostics Market Share, By Technology, By Value, 2021 (%)
  • Figure 224: United Kingdom Genetic Diagnostics Market Share, By Application, By Value, 2021 (%)
  • Figure 225: France Genetic Diagnostics Market, By Value, 2018-2028 (USD Million)
  • Figure 226: France Genetic Diagnostics Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 227: France Genetic Diagnostics Market Value, By Type, 2021 (USD Million)
  • Figure 228: France Genetic Diagnostics Market Share, By Type, By Value, 2021 (%)
  • Figure 229: France Genetic Diagnostics Market Share, By Technology, By Value, 2021 (%)
  • Figure 230: France Genetic Diagnostics Market Share, By Application, By Value, 2021 (%)
  • Figure 231: Spain Genetic Diagnostics Market, By Value, 2018-2028 (USD Million)
  • Figure 232: Spain Genetic Diagnostics Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 233: Spain Genetic Diagnostics Market Value, By Type, 2021 (USD Million)
  • Figure 234: Spain Genetic Diagnostics Market Share, By Type, By Value, 2021 (%)
  • Figure 235: Spain Genetic Diagnostics Market Share, By Technology, By Value, 2021 (%)
  • Figure 236: Spain Genetic Diagnostics Market Share, By Application, By Value, 2021 (%)
  • Figure 237: Rest of Europe Genetic Diagnostics Market, By Value, 2018-2028 (USD Million)
  • Figure 238: Rest of Europe Genetic Diagnostics Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 239: Rest of Europe Genetic Diagnostics Market Value, By Type, 2021 (USD Million)
  • Figure 240: Rest of Europe Genetic Diagnostics Market Share, By Type, By Value, 2021 (%)
  • Figure 241: Rest of Europe Genetic Diagnostics Market Share, By Technology, By Value, 2021 (%)
  • Figure 242: Rest of Europe Genetic Diagnostics Market Share, By Application, By Value, 2021 (%)
  • Figure 243: Market Value of the Asia Pacific is expected to grow from USD 1905.85 Mn to USD 4434.79 Mn in 2028
  • Figure 244: Asia Pacific Genetic Diagnostics Market is expected to foresee an absolute opportunity of USD 2528.95 Mn during 2018-2028
  • Figure 245: Market Value, by Type
  • Figure 246: Market Value, by Technology
  • Figure 247: Top 3 Countries of Genetic Diagnostics Market in Americas
  • Figure 248: Basis Point Analysis of Asia Pacific Genetic Diagnostics Market, By Country (2022,2028)
  • Figure 249: Market Opportunity Analysis of Asia Pacific Genetic Diagnostics Market, By Country (2023-2028)
  • Figure 250: Asia Pacific Genetic Diagnostics Market Size, By Value, 2018-2021(USD MILLION)
  • Figure 251: Asia Pacific Genetic Diagnostics Market Size, By Value, 2022-2028 (USD MILLION)
  • Figure 252: Asia Pacific Genetic Diagnostics Market Share, By Application, 2021 (%)
  • Figure 253: Asia Pacific Genetic Diagnostics Market CAGR, By Type, By Value, 2018-2021, 2023-2028(%)
  • Figure 254: Basis Point Analysis of Asia Pacific Genetic Diagnostics Market, By Type (2022,2028)
  • Figure 255: Market Opportunity Analysis of Asia Pacific Genetic Diagnostics Market, By Type (2023-2028)
  • Figure 256: Asia Pacific Genetic Diagnostics Market Size, Predictive and Presymptomatic Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 257: Asia Pacific Genetic Diagnostics Market Size, Predictive and Presymptomatic Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 258: Asia Pacific Predictive and Presymptomatic Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 259: Asia Pacific Genetic Diagnostics Market Size, Diagnostics Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 260: Asia Pacific Genetic Diagnostics Market Size, Diagnostics Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 261: Asia Pacific Diagnostics Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 262: Asia Pacific Genetic Diagnostics Market Size, Prenatal and Newborn Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 263: Asia Pacific Genetic Diagnostics Market Size, Prenatal and Newborn Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 264: Asia Pacific Prenatal and Newborn Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 265: Asia Pacific Genetic Diagnostics Market Size, Pharmacogenetic Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 266: Asia Pacific Genetic Diagnostics Market Size, Pharmacogenetic Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 267: Asia Pacific Pharmacogenetic Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 268: Asia Pacific Genetic Diagnostics Market Size, Others, By Value, 2018-2021 (USD MILLION)
  • Figure 269: Asia Pacific Genetic Diagnostics Market Size, Others, By Value, 2022-2028 (USD MILLION)
  • Figure 270: Asia Pacific Others Footprint in Global Market, 2021 (% of Global Market)
  • Figure 271: Asia Pacific Genetic Diagnostics Market CAGR, By Technology, By Value, 2018-2021, 2023-2028 (%)
  • Figure 272: Basis Point Analysis of Asia Pacific Genetic Diagnostics Market, By Technology(2022,2028)
  • Figure 273: Market Opportunity Analysis of Asia Pacific Genetic Diagnostics Market, By Technology(2023-2028)
  • Figure 274: Asia Pacific Genetic Diagnostics Market Size, By Cytogenetic Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 275: Asia Pacific Genetic Diagnostics Market Size, By Cytogenetic Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 276: Asia Pacific Cytogenetic Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 277: Asia Pacific Genetic Diagnostics Market Size, By Biochemical Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 278: Asia Pacific Genetic Diagnostics Market Size, By Biochemical Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 279: Asia Pacific Biochemical Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 280: Asia Pacific Genetic Diagnostics Market Size, By Molecular Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 281: Asia Pacific Genetic Diagnostics Market Size, By Molecular Testing, By Value, 2022-2028 (USD MILLION)
  • Figure 282: Asia Pacific Molecular Testing Footprint in Global Market, 2021 (% of Global Market)
  • Figure 283: Asia Pacific Genetic Diagnostics Market CAGR, By Application, By Value, 2018-2021, 2023-2028 (%)
  • Figure 284: Basis Point Analysis of Asia Pacific Genetic Diagnostics Market, By Application (2022,2028)
  • Figure 285: Market Opportunity Analysis of Asia Pacific Genetic Diagnostics Market, By Application (2023-2028)
  • Figure 286: Asia Pacific Genetic Diagnostics Market Size, By Cancer Diagnosis, By Value, 2018-2021 (USD MILLION)
  • Figure 287: Asia Pacific Genetic Diagnostics Market Size, By Cancer Diagnosis, By Value, 2022-2028 (USD MILLION)
  • Figure 288: Asia Pacific Cancer Diagnosis Footprint in Global Market, 2021 (% of Global Market)
  • Figure 289: Asia Pacific Genetic Diagnostics Market Size, By Genetic Disease Diagnosis, By Value, 2018-2021 (USD MILLION)
  • Figure 290: Asia Pacific Genetic Diagnostics Market Size, By Genetic Disease Diagnosis, By Value, 2022-2028 (USD MILLION)
  • Figure 291: Asia Pacific Genetic Disease Diagnosis Footprint in Global Market, 2021 (% of Global Market)
  • Figure 292: Asia Pacific Genetic Diagnostics Market Size, By Cardiovascular Disease Diagnosis, By Value, 2018-2021 (USD MILLION)
  • Figure 293: Asia Pacific Genetic Diagnostics Market Size, By Cardiovascular Disease Diagnosis, By Value, 2022-2028 (USD MILLION)
  • Figure 294: Asia Pacific Cardiovascular Disease Diagnosis Footprint in Global Market, 2021 (% of Global Market)
  • Figure 295: Asia Pacific Genetic Diagnostics Market Size, By Others, By Value, 2018-2021 (USD MILLION)
  • Figure 296: Asia Pacific Genetic Diagnostics Market Size, By Others, By Value, 2022-2028 (USD MILLION)
  • Figure 297: Asia Pacific Others Footprint in Global Market, 2021 (% of Global Market)
  • Figure 298: China Genetic Diagnostics Market, By Value, 2018-2028 (USD Million)
  • Figure 299: China Genetic Diagnostics Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 300: China Genetic Diagnostics Market Value, By Type, 2021 (USD Million)
  • Figure 301: China Genetic Diagnostics Market Share, By Type, By Value, 2021 (%)
  • Figure 302: China Genetic Diagnostics Market Share, By Technology, By Value, 2021 (%)
  • Figure 303: China Genetic Diagnostics Market Share, By Application, By Value, 2021 (%)
  • Figure 304: India Genetic Diagnostics Market, By Value, 2018-2028 (USD Million)
  • Figure 305: India Genetic Diagnostics Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 306: India Genetic Diagnostics Market Value, By Type, 2021 (USD Million)
  • Figure 307: India Genetic Diagnostics Market Share, By Type, By Value, 2021 (%)
  • Figure 308: India Genetic Diagnostics Market Share, By Technology, By Value, 2021 (%)
  • Figure 309: India Genetic Diagnostics Market Share, By Application, By Value, 2021 (%)
  • Figure 310: Japan Genetic Diagnostics Market, By Value, 2018-2028 (USD Million)
  • Figure 311: Japan Genetic Diagnostics Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 312: Japan Genetic Diagnostics Market Value, By Type, 2021 (USD Million)
  • Figure 313: Japan Genetic Diagnostics Market Share, By Type, By Value, 2021 (%)
  • Figure 314: Japan Genetic Diagnostics Market Share, By Technology, By Value, 2021 (%)
  • Figure 315: Japan Genetic Diagnostics Market Share, By Application, By Value, 2021 (%)
  • Figure 316: Australia Genetic Diagnostics Market, By Value, 2018-2028 (USD Million)
  • Figure 317: Australia Genetic Diagnostics Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 318: Australia Genetic Diagnostics Market Value, By Type, 2021 (USD Million)
  • Figure 319: Australia Genetic Diagnostics Market Share, By Type, By Value, 2021 (%)
  • Figure 320: Australia Genetic Diagnostics Market Share, By Technology, By Value, 2021 (%)
  • Figure 321: Australia Genetic Diagnostics Market Share, By Application, By Value, 2021 (%)
  • Figure 322: Rest of Asia Pacific Genetic Diagnostics Market, By Value, 2018-2028 (USD Million)
  • Figure 323: Rest of Asia Pacific Genetic Diagnostics Market, CAGR, By Value, 2018-2021, 2023-2028 (%)
  • Figure 324: Rest of Asia Pacific Genetic Diagnostics Market Value, By Type, 2021 (USD Million)
  • Figure 325: Rest of Asia Pacific Genetic Diagnostics Market Share, By Type, By Value, 2021 (%)
  • Figure 326: Rest of Asia Pacific Genetic Diagnostics Market Share, By Technology, By Value, 2021 (%)
  • Figure 327: Rest of Asia Pacific Genetic Diagnostics Market Share, By Application, By Value, 2021 (%)
  • Figure 328: Market Value of the Middle East & Africa is expected to grow from USD 754 Mn to USD 1346 Mn in 2028
  • Figure 329: Middle East & Africa Genetic Diagnostics Market is expected to foresee an absolute opportunity of USD 592.09 Mn during 2018-2028
  • Figure 330: Market Value by Type
  • Figure 331: Market Value by Technology
  • Figure 332: Market Value by Application
  • Figure 333: Middle East & Africa Genetic Diagnostics Market Size, By Value, 2018-2021(USD MILLION)
  • Figure 334: Middle East & Africa Genetic Diagnostics Market Size, By Value, 2022-2028 (USD MILLION)
  • Figure 335: Middle East & Africa Genetic Diagnostics Market Share, By Application, 2021 (%)
  • Figure 336: Middle East & Africa Genetic Diagnostics Market CAGR, By Type, By Value, 2018-2021, 2023-2028(%)
  • Figure 337: Basis Point Analysis of Middle East & Africa Genetic Diagnostics Market, By Type (2022,2028)
  • Figure 338: Market Opportunity Analysis of Middle East & Africa Genetic Diagnostics Market, By Type (2023-2028)
  • Figure 339: Middle East & Africa Genetic Diagnostics Market Size, Predictive and Presymptomatic Testing, By Value, 2018-2021 (USD MILLION)
  • Figure 3